Paper 33 - A PHASE I TRIAL OF LYMPHODEPLETION PLUS ADOPTIVE CELL THERAPY WITH TUMOR INFILTRATING LYMPHOCYTES FOLLOWED BY HIGH-DOSE IL-2 IN ADOLESCENT AND YOUNG ADULT PATIENTS WITH SOFT TISSUE SARCOMA

Author(s)

• 

  John Mullinax, MD

  Associate Member
  Moffitt Cancer Center
  Tampa, Florida, United States

  Slides

Co-Author(s)

• JH

  Jonathan Hensel, PhD

  Quorum Innovations
  Sarasota, Florida, United States
• MR

  Madeline Rodriguez-Valentin, PhD

  Research Scientist
  Moffitt Cancer Center
  Tampa, Florida, United States
• 

  Alejandro Alfaro, BS

  Cell Therapy Technologist
  Moffitt Cancer Center
  Wesley Chapel, Florida, United States
• ER

  Elizabeth Rau, BS

  Research Associate
  Moffitt Cancer Center
  Tampa, Florida, United States
• DR

  Damon Reed, MD

  Moffitt Cancer Center
  Tampa, Florida, United States
• 

  Andrew Brohl, MD (he/him/his)

  Associate Member
  Moffitt Cancer Center
  Tampa, Florida, United States
• MD

  Mihaela Druta, MD

  H. Lee Moffitt Cancer Center and Research Institute
  Tampa, Florida, United States
• RG

  Ricardo Gonzalez, MD

  Chair, Sarcoma Department
  Moffitt Cancer Center
  Tampa, Florida, United States
• 

  Eric Toloza, MD, PhD

  Senior Member
  Moffitt Cancer Center
  Tampa, Florida, United States
• CC

  Cheryl Cox, MS

  Director of Operations, Cell Therapy Core Facility
  Moffitt Cancer Center
  Tampa, Florida, United States
• AS

  Amod Sarnaik, MD

  Senior Member
  Moffitt Cancer Center
  Tampa, Florida, United States
• SP

  Shari Pilon-Thomas, PhD

  Senior Member
  Moffitt Cancer Center
  Tampa, Florida, United States